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EVALUATION OF BODE INDEX AS A PREDICTOR OF  
SEVERITY AND ITS CORRELATION WITH PULMONARY 
HYPERTENSION IN COPD PATIENTS 
ABSTRACT 
INTRODUCTION: 
 Chronic obstructive pulmonary disease (COPD) is a major cause of 
mortality and morbidity and health care costs worldwide. The COPD severity is 
generally assessed on the basis of a single parameter i.e forced expiratory volume 
in one second (FEV1). However, the systemic manifestations of COPD were not 
reflected by the FEV1. Hence, a multidimensional grading system which assesses 
the respiratory and systemic expressions of COPD is designed to predict outcome 
in these patients. These variables were used to construct the multidimensional 
BODE index which is a 10-point scale in which higher scores indicate the more 
severe nature of the disease and higher risk of complications and death.  
AIMS AND OBJECTIVES 
 To compare the severity of COPD using BODE index than primary lung 
function test alone. 
 To determine whether higher BODE index in chronic obstructive 
pulmonary disease correlates with more years of cigarette smoking and 
more days of hospitalisation. 
 To determine whether higher BODE index is associated with more severe 
systemic compilcations in the form of cardiac involvement (PHT). 
 
 
METHODOLOGY: 
COPD patients who attended our outpatient clinic / admitted as inpatient at 
the Govt.Kilpauk Medical College & hospital in the department of General 
Medicine were enrolled into the study.  
The BODE index was calculated for each patient using the body mass 
index, the threshold value of FEV1, the distance walked in 6 min, and the score on 
the Modified Medical Research Council (MMRC) dyspnea scale. The patients 
received points ranging from 0 (lowest value) to 3 (maximal value). For Body 
mass index the values were 0 (>21) or 1 (<21). The scores for FEV1 were 0 (more 
than or equal to 65%), 1 (50 – 64%), 2 (36 – 49%) and 3 (less than or equal to 
35%). The 6 minute walk test scores were 0 (> 350 ms), 1 (250 – 350 ms),  
2 (150 – 249 ms) and 3 (< 150 ms). The MMRC dyspnea class 0 and I were given 
0 points, class II – 1 point, class III – 2 points and class IV – 3 points. The BODE 
score of 0 – 2 was taken as mild COPD. Scores between 3-5 was considered as 
moderate disease and those more than or equal to 6 was considered as severe 
COPD. 
RESULTS:  
 A total of 81 patients with COPD were enrolled in the study. All 81 patients 
were males. Among the patients with COPD, 21 (25.9%), 27 (33.3%), 28 (34.6%) 
and 5 (62%) belongs to age 41 – 50years, 51 – 60 years, 61 – 70years and 71 – 80 
years respectively. Most patients are in the age group of 51 – 70 years. Of the total 
81 patients enrolled in the study, 42(51.9%) comes under Mild COPD, 15(18.5%) 
comes under Moderate COPD and 24(29.6%) comes under Severe COPD 
categories. On analysing the distribution of number of exacerbations in relation to 
the severity of COPD categories, it was observed that the mean number of 
exacerbations were 0.62±1.15, 5.53±1.96 and 14.38±1.95 in mild, moderate and 
severe category of COPD. Among 81 patients enrolled in the study, 53 (65.4%) 
patients had no changes in ECG but only 28 (34.6%) patients had ECG changes i.e 
‘P’ Pulmonale and Right axis deviation (RAD). Among the 81 patients included in 
the study, 30(37%) had Mild PHT, 14(17.3%) had Moderate PHT, 26(32.1%) had 
Severe PHT and 11(13.6%) had no evidence of PHT. On analysing the distribution 
of BODE scores in relation to the PHT categories, it was observed that the mean 
BODE Scores were 1.00±1.29, 3.50±1.79 and 7.62±1.68 in mild, moderate and 
severe category of PHT. On analysing the distribution of BODE score in relation 
to the severity of COPD categories, it was observed that the mean BODE Scores 
were 0.57±0.63, 4.13±0.92 and 8.00±1.25 in mild, moderate and severe category 
of  COPD.  
CONCLUSION: 
 BODE Index can be used as a very useful and reliable index to assess the 
severity of Chronic Obstructive Pulmonary Disease (COPD). BODE index is 
directly correlated with the number of exacerbations. As the Smoking intensity 
and the Smoking Pack Years increases the BODE Index also increases. PHT 
increases with the severity of COPD as assessed by BODE index.  
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